Olema Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q2 EPS results. Also, HC Wainwright & Co. lowered its price target on the stock from $38 to $36.

Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.

OLMA

0.00

Olema Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q2 EPS results. Also, HC Wainwright & Co. lowered its price target on the stock from $38 to $36.